NASDAQ:CPRX - US14888U1016 - Common Stock
We assign a fundamental rating of 8 out of 10 to CPRX. CPRX was compared to 542 industry peers in the Biotechnology industry. CPRX gets an excellent profitability rating and is at the same time showing great financial health properties. CPRX is evaluated to be cheap and growing strongly. This does not happen too often! With these ratings, CPRX could be worth investigating further for value and growth and quality investing!.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 21.47% | ||
ROE | 24.38% | ||
ROIC | 21.45% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 43.58% | ||
PM (TTM) | 37.36% | ||
GM | 85.78% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | 0 | ||
Altman-Z | 15.31 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 6.71 | ||
Quick Ratio | 6.55 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 11.91 | ||
Fwd PE | 11.23 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 8.75 | ||
EV/EBITDA | 6.29 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NASDAQ:CPRX (9/4/2025, 12:24:04 PM)
19.65
-0.14 (-0.71%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 11.91 | ||
Fwd PE | 11.23 | ||
P/S | 4.31 | ||
P/FCF | 8.75 | ||
P/OCF | 8.74 | ||
P/B | 2.81 | ||
P/tB | 3.35 | ||
EV/EBITDA | 6.29 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 21.47% | ||
ROE | 24.38% | ||
ROCE | 28.34% | ||
ROIC | 21.45% | ||
ROICexc | 89.37% | ||
ROICexgc | 270.38% | ||
OM | 43.58% | ||
PM (TTM) | 37.36% | ||
GM | 85.78% | ||
FCFM | 49.19% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | 0 | ||
Debt/EBITDA | 0 | ||
Cap/Depr | 0.99% | ||
Cap/Sales | 0.07% | ||
Interest Coverage | 165.59 | ||
Cash Conversion | 97.81% | ||
Profit Quality | 131.65% | ||
Current Ratio | 6.71 | ||
Quick Ratio | 6.55 | ||
Altman-Z | 15.31 |